These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3703318)

  • 41. [Clinical effects of FUT-187 in reflux esophagitis after gastrectomy].
    Toge T; Hirai T; Takiyama W; Takashima N; Kawano K; Tamura Y; Nishimawari K; Iwamori S; Nakanishi K; Kono H
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):539-46. PubMed ID: 7887646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [H2 receptor blockaders: domains for oral use. Indications for cimetidine and ranitidine in gastroenterology].
    Hotz J
    Fortschr Med; 1984 Feb; 102(8):203-4. PubMed ID: 6086477
    [No Abstract]   [Full Text] [Related]  

  • 43. [Early phase II study of FUT-187 (sepimostat mesilate) on reflux esophagitis--mainly on postgastrectomy reflux esophagitis].
    Abe O; Yoshino K; Kimura K; Suzuki H; Aoki T; Hiki Y; Mitomi T; Makuuchi H
    Gan To Kagaku Ryoho; 1994 May; 21(6):845-52. PubMed ID: 8185343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
    Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
    Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
    [No Abstract]   [Full Text] [Related]  

  • 45. Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity.
    Kono K; Takahashi A; Sugai H; Umekawa T; Yano T; Kamiyasu K; Teramatsu M; Fujii H
    Am J Surg; 2005 Sep; 190(3):412-7. PubMed ID: 16105528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment interruptus: the need for withdrawal.
    Hassall E
    Am J Gastroenterol; 2007 Sep; 102(9):2108-9. PubMed ID: 17727443
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical review of lansoprazole.
    Lockhart SP
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of Thymobiol in the treatment of chronic ulcerations of the digestive tract].
    Fouet P; Denez B; Zimmermann P
    Med Chir Dig; 1976; 5(1):59-62. PubMed ID: 1011890
    [No Abstract]   [Full Text] [Related]  

  • 49. [Renewing treatment of reflux esophagitis].
    Ovaska J
    Duodecim; 1997; 113(1):39-44. PubMed ID: 11370053
    [No Abstract]   [Full Text] [Related]  

  • 50. PPIs vs H2RAs for erosive reflux esophagitis.
    King VJ
    J Fam Pract; 1998 Mar; 46(3):199-200. PubMed ID: 9519012
    [No Abstract]   [Full Text] [Related]  

  • 51. [The treatment of reflux esophagitis in patients with a Helicobacter infection of the gastric mucosa].
    Chakŭrski I; Prodanova M; Penkova M; Todorova K
    Vutr Boles; 1999; 31(2-3):25-7. PubMed ID: 10847137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Control of reflux esophagitis in gastroresected patients. Medical treatment with alginic acid].
    Triggiani E; Tricarico A; Liguori G
    Minerva Chir; 1984 Jun; 39(11):869-74. PubMed ID: 6483217
    [No Abstract]   [Full Text] [Related]  

  • 53. [Meta-analysis in clinical research].
    Pignon JP
    Presse Med; 1988 Dec; 17(44):2328-30. PubMed ID: 2974967
    [No Abstract]   [Full Text] [Related]  

  • 54. Personal experience in TCM treatment of reflux esophagitis.
    Hong L
    J Tradit Chin Med; 2003 Sep; 23(3):175-6. PubMed ID: 14535176
    [No Abstract]   [Full Text] [Related]  

  • 55. Ranitidine for improvement of treatment-resistant psoriasis.
    Nielsen HJ; Nielsen H; Georgsen J
    Arch Dermatol; 1991 Feb; 127(2):270. PubMed ID: 1991001
    [No Abstract]   [Full Text] [Related]  

  • 56. Risk factors for healing and relapse of esophagitis (II).
    Koelz HR; Schmid P; Blum AL
    Gastroenterology; 1987 Aug; 93(2):434. PubMed ID: 3596178
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment with ranitidine in reflux esophagitis].
    Balanzoni S; Bagioni P; Turicchia GU; Campagnoni R; Sansone G; Tampieri I
    Minerva Dietol Gastroenterol; 1986; 32(1):35-8. PubMed ID: 3703318
    [No Abstract]   [Full Text] [Related]  

  • 58. [2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis].
    Rohner HG; Wienbeck M
    Z Gastroenterol; 1986 Aug; 24(8):396-402. PubMed ID: 3532593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Etintidine versus ranitidine in the treatment of reflux esophagitis].
    Wienbeck M; Rohner HG; Hüttemann W; Pelz W
    Dtsch Med Wochenschr; 1986 Sep; 111(39):1501-2. PubMed ID: 3757813
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis.
    Fielding JF; Doyle GD
    Ir Med J; 1984 Nov; 77(11):356-7. PubMed ID: 6096296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.